Montelukast for Acute Bronchiolitis and Postbronchiolitis Viral Induced Wheezing

• Status: Completed
• Trial end date: 2011-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the current study is to evaluate the effect of Montelukast in treatment of acute bronchiolitis and postbronchiolitis viral induced wheezing of infants 3 to 12 months of age in Bandar Abbas Children' hospital.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hormozgan University of Medical Sciences
• Treatments: Montelukast

Criteria

Inclusion Criteria:

• infant in 3-12 months of age with first episode of wheezing or bronchiolitis

• written informed consent by parents

Exclusion Criteria:

• Previous wheezing episode or confirmed asthma or bronchiolitis

• recent bronchodilator use

• immune deficient

• immunosuppressive drug use

• croup or pneumonia diagnosis

• loss of follow up